Members
Neurotrope Bioscience
Cerecor
Amarantus
Ontario Brain Institute
Aptuit
Naurex
ElMindA
Cambridge Cognition
Edge Therapeutics
Janssen Pharmaceuticals
Heidelberg Engineering
Third Rock Ventures
Orasi Medical
Centerstone Research Inst.
Satori Pharma
Fornap Pharma
Intelect Medical
Biovail/Valeant
Alliance for Aging Research
Adjuvant Global Advisors
Michael J. Fox Foundation for Parkinson's Research
Alzheimer Research Forum
Brainstorm Research Foundation
Advanced Brain Monitoring
Alfred Mann Foundation
Brain Injury Association of America
Aberdare Ventures
RedPlane
North American Neuromodulation Society
Neurolutions
Bernstein Neurotechnology
Concordant Rater Systems
ArunA Biomedical
NeoStim
NeuroWave Systems
Cleveland Medical Devices
Flocel
Banyan Biomarkers
Pfizer
NeuroImage Inc.
Bay City Capital
MedAvante
Prize4Life
Johns Hopkins Brain Science Institute
NeuroNascent
CureNeuro
NeuroNexus Technologies
Gladstone Institute of Neurological Disease
Traxion Therapeutics
Satoris
PsychoGenics
BrainScope
Aspect Medical Systems
Posit Science
Alexza Pharmaceuticals
Int'l Neuromodulation Society
Advanced Brain Technologies
NAMI
Acorda Therapeutics
NeuroProtect
Medivation
ACADIA Pharmaceuticals
Myelin Repair Foundation
Xenoport
Parkinson's Research Foundation
Cortechs Labs

Neurodegenerative Drug Incentive Initiative

NIO is spearheading new Federal legislation aimed at accelerating investment and innovation in the area of disease-modifying therapies for neurodegenerative diseases. Learn more

Recent News

05.05.13 Use Brain Power for Video Games - CCTV

05.03.13 First Ever NeuroGaming Conference Brings Together over 300 in San Francisco

03.14.13 NeuroGaming Conference Features over 50 Leaders Speaking About the Future

02.06.13 NIO Launches NeuroGaming Conference to Accelerate Neurotechnology Development

12.03.12 NIO Supports Senator Warrens Amendent to the 2013 Department of Defense Authorization Bill

10.15.12 NIO Hosts Over 100 Neurotech Leaders for PartnerFest in New Orleans

09.15.12 NIO to Host PartneringFest for Neurotech Community at Society For Neuroscience in New Orleans

06.10.12 NINDS and NIO Host Alternative Funding Methods Through NIH Neuroscience Blueprint

05.21.12 Neurotech 2012 Conference Brings Together 250 Leaders, panel highlights

05.01.12 Policy Tour Success and Next Steps for the Neurodegenerative Drug Incentive Initiative

03.15.12 NIO and NeuroInsights Announce Full Speaker Line Up at Neurotech 2012

01.15.12 NIO Announces 2012 Public Policy Tour, March 20

09.20.11 NIO FDA Counsel Contributes to New Medical Device Law and Regulation Answer Book

07.08.11 NIO Announces European Neurotech Conference in Helsinki, Finland, Sept. 7-8

Receive NIO updates

Upcoming Events

May 6-7, 2013 US-Israel Neurotech Business Exchange, Charleston, South Carolina

May 23-24, 2013 8th annual NIO Investing/Partnering Conference, San Francisco

Sept. 4-5, 2013 2nd binannual European Neurotech Investing Conference, Helsinki

Click to Get Report

Industry Leadership

NIO's National Neurotechnology Intiative
Introduced in House
and Senate
(H.R.1483) and (S.586)

(More)

NIO is spearheading new Federal legislation aimed to accelerate translational neurotech innovation and improving the timeliness of the FDA review process for neuroscience drugs, devices and diagnostics.

Advancing the Brain Industry Together

Home

About NIO

Public Policy

Programs

Membership

Member List

News

Contact Us